The 5th (2022) China Medical Device Innovation and Entrepreneurship Competition in the category of artificial intelligence and medical robots ended on August 27 at the Tianmu Pharmaceutical Port Pharmaceutical Industry Incubation Park in Lin'an District, Hangzhou.

40 excellent project teams from all over the country conducted an "AI Showdown" in the medical device industry in Lin'an, presenting a colorful and fierce competition to the judges, experts, various investment and financing institutions, and business representatives on site.

This competition focuses on high-quality artificial intelligence and medical robot projects, covering the current application direction and innovative technology of emerging medical devices. The judges of the competition are composed of well-known experts in clinical, technical, testing, investment and other fields in the industry, who will give comprehensive scores on the clinical value, social value, innovation and technology of the project. Some experts said that the industry generally agrees that medical robots are the future development direction of the medical industry, so no matter whether it is primary or secondary, the capital market pays attention and enthusiasm to this.

Among them, the "Life Science Laboratory Automation Solution" project represented by Guangdong Bogong Medical Technology Co., Ltd. (Bogong Technology) was shortlisted for the top three.

Bogong Technology Co., Ltd. focuses on the R&D, design, production and sales of AI intelligent robot medical equipment and intelligent medical scene application solutions, builds the first brand of intelligent robot medical equipment, and is committed to the development of easy-to-operate, flexible and safe medical robot equipment. To help users improve work efficiency. The company adheres to the concept of "achieve customers and work hard", has a large number of successful application cases of intelligent equipment in domestic medical stem cell industry laboratories, and is the leader of stem cell cultivation robots.

In 2021, Bogong Technology's first stem cell cultivation robot was born and successfully delivered, which effectively improved the pain points of the domestic laboratory automation industry, realized laboratory automation in the field of life sciences, and greatly improved laboratory research and production efficiency. In 2022, Bogong Technology's life science laboratory automation solution has been implemented in many domestic cell leading companies, and achieved tens of thousands of experimental zero-error results in complex scenarios, effectively solving the problem of low efficiency in biological laboratories, High error, uneven product quality and other problems.

At present, Bogong Technology already has the core advantages of laboratory automation in the domestic life science field, has rich experience in project cooperation, and can provide users with customized laboratory automation solutions.